chemokine | Media Room | PressRelease.com

Press Release Jul 23, 2019

Novel Drug Being Developed for Cancer Indications and HIV Prevention Demonstrates Best-in-Class Potency

Press Release Jun 20, 2019

Orion Biotechnology Reports Additional Positive Preclinical Data for OB-002 in the Treatment of Colorectal Cancer

Press Release Jun 10, 2019

Orion Biotechnology Announces Receipt of Pre-IND Guidance From the United States FDA on the Further Development of OB-002O as a Potential Treatment for Solid Tumors

Press Release Apr 16, 2019

The National Centre for Research and Development Awards Orion Biotechnology With a Grant to Progress Development of a Treatment for Advanced Colorectal Cancer

Press Release Dec 8, 2010

Phillip K Weck, Vice President of Centocor To Speak at 9th Cytokines Conference Jan 27, 2011 In Cali

Golimumab is currently offered in the SmartJect® auto injector and UltraSafe® pre-filled syringes. SmartJect® and monthly dosing distinguish golimumab from other anti-TNFs and provide patient friendly administration of the product.